ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
+0.24 (0.43%)
Jul 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 55.00 - 56.26
52 week 45.74 - 75.33
Open 55.00
Vol / Avg. 1.08M/850,470.00
Mkt cap 7.88B
P/E 22.68
Div/yield 0.28/2.00
EPS 2.47
Shares 140.92M
Beta 0.67
Inst. own 53%
Jul 30, 2015
Q4 2015 ResMed Inc Earnings Call - Webcast
Jul 30, 2015
Q4 2015 ResMed Inc Earnings Release
Jun 10, 2015
ResMed Inc at William Blair Annual Growth Stock Conference - Webcast
Jun 5, 2015
ResMed Inc. 2015 Investor Day - Webcast
May 6, 2015
ResMed Inc at Deutsche Bank Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 21.53% 22.20%
Operating margin 25.06% 26.05%
EBITD margin - 31.18%
Return on average assets 15.85% 15.10%
Return on average equity 23.36% 20.50%
Employees 4,100 -
CDP Score - -


9001 Spectrum Center Blvd.
United States - Map
+1-858-7462400 (Phone)
+1-858-8365501 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


ResMed Inc. is a holding company for the ResMed Group. The Company, through its subsidiaries, designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea. The Company offers various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. The Company has manufacturing operations in Australia, Singapore, France, Germany, Malaysia and the United States. Its distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. The Company also offers services to streamline order fulfillment, including VGM, PPM, CpapDropShip and JaySec. The Company’s subsidiaries include ResMed Hong Kong Limited, ResMed Limited, ResMed India Private Limited and ResMed Taiwan Co., Ltd.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 54
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 42
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Don Darkin President - Sleep-disordered Breathing Strategic Business Unit
Age: 61
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 51
Bio & Compensation  - Reuters
Anne Reiser President, Europe
Age: 53
Bio & Compensation  - Reuters
David Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 67
Bio & Compensation  - Reuters